Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It ...

We're thrilled to have you with us for Flotek's fourth quarter and full year 2025 earnings conference call. Today, I'm joined by Ryan Ezell, Chief Executive Officer; and Bond Clement, Chief Financial ...